Search by Drug Name or NDC

    NDC 24201-0237-01 fludarabine phosphate 25 mg/mL Details

    fludarabine phosphate 25 mg/mL

    fludarabine phosphate is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Leucadia Pharmaceuticals. The primary component is FLUDARABINE PHOSPHATE.

    Product Information

    NDC 24201-0237
    Product ID 24201-237_80dc840b-7607-2efd-e053-2a91aa0a2ed2
    Associated GPIs 21300025102120
    GCN Sequence Number 016551
    GCN Sequence Number Description fludarabine phosphate VIAL 50 MG INTRAVEN
    HIC3 V1B
    HIC3 Description ANTINEOPLASTIC - ANTIMETABOLITES
    GCN 32981
    HICL Sequence Number 006308
    HICL Sequence Number Description FLUDARABINE PHOSPHATE
    Brand/Generic Generic
    Proprietary Name fludarabine phosphate
    Proprietary Name Suffix n/a
    Non-Proprietary Name fludarabine phosphate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 25
    Active Ingredient Units mg/mL
    Substance Name FLUDARABINE PHOSPHATE
    Labeler Name Leucadia Pharmaceuticals
    Pharmaceutical Class Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA076349
    Listing Certified Through 2022-12-31

    Package

    NDC 24201-0237-01 (24201023701)

    NDC Package Code 24201-237-01
    Billing NDC 24201023701
    Package 1 VIAL in 1 CARTON (24201-237-01) / 2 mL in 1 VIAL
    Marketing Start Date 2017-12-13
    NDC Exclude Flag N
    Pricing Information N/A